The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel
Open accessAbstract
The coronavirus disease 2019 (COVID-19) pandemic has created new and unpredictable challenges for modern medicine and healthcare systems. Preliminary reports have demonstrated that older age, previous cardiovascular disease, diabetes, and hypertension are risk factors for increased mortality.1 Data on the cardiac affinity of the virus and its potential to harm the cardiovascular system and the mechanisms by which this occurs are sparse.2,3A systemic infection generally increases demand on the heart, and can exacerbate underlying cardiac conditions. When the lungs are heavily involved, as seen in COVID-19 patients, this may have a major impact on cardiac function, particularly that of the right ventricle. Finally, COVID-19 may have direct effects on the heart, as may some drugs being used in its treatment. The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for COVID-19 and is transmitted by droplets from person to person.4 Echocardiographers in particular, and cardiac imagers more generally, are in close contact with patients and therefore likely to have a high risk of being infected. To decrease the risk of patient to patient, patient to imager, and imager to patient contamination, the indication for any cardiac imaging test should be carefully considered, and only those tests considered essential to patient care performed. Cardiologists and cardiology departments are heavily affected by this rapidly changing situation.5 The COVID-19 pandemic also increases the burden on cardiac imaging services generally. However, given its wide availability and key role as a bedside test, echocardiography is the most affected cardiac imaging modality. Common challenges faced by all cardiac imaging modalities during the pandemic include limited expert staff availability [sickness or redeployment in prioritized areas, such as intensive care units (ICUs)] and the risk of peri-procedural transmission of SARS-CoV-2 between patients and staff. The scope of these EACVI recommendations is to summarize how these challenges may be addressed during the pandemic. In particular, we focus upon bold prioritization and provide specific indications and recommendations on how to perform an echocardiogram during the pandemic whilst safeguarding both patient and staff. Some of our recommendations relating to the appropriate use of imaging modalities in the COVID-19 pandemic must be considered only as expert advice due to the lack of evidence-based scientific data and the rapidly changing global situation. For all modalities, the main question is: ‘Will undertaking this study substantially change patient management or be lifesaving?’ If the answer is yes, use the imaging modality with the best capability to meet the request, but also consider the safety of medical staff regarding exposure. It is very important that every cardiac imaging study is performed appropriately to minimize the risk of further dissemination of the disease (Key point 1 and Figure 1). This question needs to be considered in detail for each echocardiogram requested given the risk of cross-infection and the consumption of personal protective equipment. However, computed tomography (CT) and cardiac magnetic resonance (CMR) may also have a significant potential for contamination of personnel and patients, especially linked to transportation, but also via direct contamination during the scan. In parallel with echocardiography and other imaging modalities, CMR and CT should only be performed if the expected information is critical for clinical management and can be justified in the face of the following considerations: (i) risk of transportation of critically ill or high-risk patients; (ii) time duration of CMR; (iii) possible/significant risk of infection for professionals (technicians, physicians, nurses, and other personnel); (iv) possible/significant risk of contamination of equipment and facilities, leading to the need for full disinfection; and (v) whether the test is necessary to confirm the diagnosis, or whether this can be achieved based simply upon the clinical probability. In many countries, imaging exams for elective non-urgent patients have been cancelled or postponed. However, cardiac imaging is still being widely requested for inpatients or those presenting to the Emergency Department (Key point 2). The chest radiograph is the most commonly used imaging test in COVID-19 patients, but CT is frequently used to confirm COVID-19 pneumonia. Whilst this might conceivably provide some possible synergies and opportunities to gain information about the cardiovascular system, this requires bespoke protocols that are not widely employed. Dedicated coronary CT angiography is therefore usually required. One emerging clinical issue is that numerous patients with pneumonia caused by COVID-19 experience elevated troponins with and without signs of obstructive coronary artery disease. In this situation, coronary CT angiography can be of great help in
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Self-citationHabib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Donofrio, M. T., Moon-Grady, A. J., Hornberger, L. K., Copel, J. A., Sklansky, M. S., Abuhamad, A., Cuneo, B. F., Huhta, J. C., Jonas, R. A., Krishnan, A., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437597.44550.5d · Cited by 1,275
Coronaviruses and the cardiovascular system: acute and long-term implications
Xiong, T.-Y., Redwood, S., Prendergast, B., & Chen, M. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa231 · Cited by 831
Findings of lung ultrasonography of novel corona virus pneumonia during the 2019–2020 epidemic
Chinese Critical Care Ultrasound Study Group (CCUSG), Peng, Q.-Y., Wang, X.-T., & Zhang, L.-N. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05996-6 · Cited by 737
Lancellotti, P., Price, S., Edvardsen, T., Cosyns, B., Neskovic, A. N., Dulgheru, R., Flachskampf, F. A., Hassager, C., Pasquet, A., Gargani, L., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu210 · Cited by 182
Self-citationCardim, N. M., Dalen, H., Voigt, J., Ionescu, A. A., Price, S., Nešković, A., Edvardsen, T., Galderisi, M., Sicari, R., Donal, E., et al. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey145 · Cited by 143
Self-citation
Cited by
Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Madhur, M. S., Tomaszewski, M., Maffia, P., D’Acquisto, F., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa106 · Cited by 1,440
Global evaluation of echocardiography in patients with COVID-19
Dweck, M. R., Bularga, A., Hahn, R. T., Bing, R., Lee, K. K., Chapman, A. R., White, A., Salvo, G. D., Sade, L. E., Pearce, K., et al. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa178 · Cited by 439
Self-citationCardiac Troponin for Assessment of Myocardial Injury in COVID-19
Sandoval, Y., Januzzi, J. L., & Jaffe, A. S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.06.068 · Cited by 438
Heart Failure in COVID-19 Patients: Prevalence, Incidence and Prognostic Implications
Rey, J. R., Caro-Codón, J., Rosillo, S. O., Iniesta, Á. M., Castrejón-Castrejón, S., Marco-Clement, I., Martín-Polo, L., Merino-Argos, C., Rodríguez-Sotelo, L., García-Veas, J. M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1990 · Cited by 318
Metadata
- Authors
- Skulstad, H., Cosyns, B., Popescu, B. A., Galderisi, M., Salvo, G. D., Donal, E., Petersen, S., Gimelli, A., Haugaa, K. H., Muraru, D., Almeida, A. G., Schulz-Menger, J., Dweck, M. R., Pontone, G., Sade, L. E., Gerber, B., Maurovich-Horvat, P., Bharucha, T., Cameli, M., Magne, J., Westwood, M., Maurer, G., & Edvardsen, T.
- Venue
- European Heart Journal - Cardiovascular Imaging
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04-03
- Volume
- 21
- Issue
- 6
- Pages
- 592-598
- ISSN
- 2047-2404 (ISSN-L)
- 2047-2412
- OpenAlex
- W3014141859
- Cited by
- 289
- References
- 12
- FWCI
- 21.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. https://app.cochat.ai/papers/10.1093/ehjci/jeaa072
- The paper
- Skulstad, H., Cosyns, B., Popescu, B. A., Galderisi, M., Salvo, G. D., Donal, E., Petersen, S., Gimelli, A., Haugaa, K. H., Muraru, D., Almeida, A. G., Schulz-Menger, J., Dweck, M. R., Pontone, G., Sade, L. E., Gerber, B., Maurovich-Horvat, P., Bharucha, T., Cameli, M., . . . Edvardsen, T. (2020). COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jeaa072
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.